Key works closely with emerging and established life sciences companies developing therapeutics, medical devices, diagnostics and digital health technologies. Key helps clients structure and complete critical transactions, from in-licensing patents that form the foundation of the companies’ patent portfolio, through services arrangements with CMOs, CROs and other development partners, and eventually toward commercial partnering of the program, sale of the company or other exit transactions. In addition to licensing collaborations, Key supports venture ﬁnancings—representing both startups and venture capital ﬁrms—as well as mergers and acquisitions matters.
Key has experience structuring joint development arrangements between collaborators coming from both similar and widely disparate core technological competencies, often involving complex IP allocation issues. He assists companies in establishing long-term research collaborations with universities that go beyond typical sponsored research and technical services agreements. Key also works with research accelerators working in innovative ways to facilitate collaborative research among investigators from different research institutions worldwide, successfully navigating the conﬂicting IP, publication and liability positions of participating institutions.